Product Images Imiquimod
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Imiquimod NDC 45802-368 by Padagis Israel Pharmaceuticals Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
2H162RCC2
Imiquimod Cream 5% is a topical medication used for the treatment of actinic keratosis and superficial basal cell carcinoma. It comes in 24 single-use packets, with a net weight of 0.25g per packet and 6g per carton. It is for dermatologic use only and should not be used for ophthalmic purposes. The provided text appears to include some extra unrelated characters and random symbols.*
image 01
image 02
This is a clinical trial report of Imiquimod Cream, 5% Vehicle Cream for the treatment of external genital warts. There were 209 participants enrolled in the study, and the figure shows subject accountability throughout the trial period. Some participants completed 16 weeks of treatment while others withdrew. Out of the total participants, some cleared of warts and completed 12 weeks of follow-up, while others were lost to follow-up or experienced recurrences.*
image 04
This text is a warning for the use of Imiquimod Cream, specifying that it should only be used topically on the skin and not in or near the mouth, eyes, nose, or vagina.*
serialization template
This text provides a template for inserting a product's serial number, lot number, and expiration date. It does not provide any additional information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.